Crypto · IPO · Market Intelligence

Clear Signals for Market Momentum

Track IPOs, private companies, and crypto-related market movements in one modern intelligence platform.

Explore Data

Lior mor

903 POSTS

Exclusive articles:

SKN | Guinness Atkinson Funds: Investment Manager Expands Its Thematic Fund Platform

Guinness Atkinson Funds is not a conventional IPO candidate but an established U.S. investment fund complex offering mutual funds and exchange-traded funds across themes...

SKN | Alamar Biosciences Shares Surge More Than 30% as Proteomics Platform Draws Investor Attention

Alamar Biosciences, Inc. (Nasdaq: ALMR) recorded a sharp increase in its share price, with the stock closing at $36.57, up $8.58, or 30.65%, according...

SKN | GigCapital10 Files for $220 Million IPO to Target Aerospace and TMT Businesses

GigCapital10, a blank check company led by longtime SPAC sponsor Avi Katz, has filed with the U.S. Securities and Exchange Commission to raise up...

SKN | Leader’s Advantage Acquisition Corp. Units: A $150 Million SPAC IPO Targets Chemicals and Healthcare

Leader’s Advantage Acquisition Corp. is moving toward a Nasdaq IPO that would raise approximately $150 million through the sale of 15 million units priced...

SKN | Collective Mining Ltd. Common Shares: A Strategic Gold Exploration Play Enters the Spotlight

Collective Mining Ltd. is attracting investor attention as it advances its Colombian mineral exploration strategy and expands its access to public-market capital. Unlike a...

Breaking

SKN | Five U.S. IPO Calendar Events Highlight Selective Market Activity as New Listings Test Investor Demand

Key Points: Five offerings were listed for pricing on...

SKN | Davion Healthcare Plc: Assessing the Ordinary Shares and the Company’s Market Prospects

Davion Healthcare Plc ordinary shares represent a potential investment...

SKN | Forge Nano Holdings Warrants: Investors Weigh the Potential of Advanced Materials Technology

Forge Nano Holdings Inc. warrants offer investors a way...

SKN | Interpace Biosciences Stock: Diagnostics Business Faces a Critical Test of Growth and Profitability

Interpace Biosciences, Inc. operates in the molecular diagnostics market,...
spot_imgspot_img